Financhill
Buy
57

SRRK Quote, Financials, Valuation and Earnings

Last price:
$44.94
Seasonality move :
-1.5%
Day range:
$43.95 - $46.17
52-week range:
$6.76 - $46.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
92.18x
P/B ratio:
53.86x
Volume:
365.8K
Avg. volume:
1.2M
1-year change:
142.99%
Market cap:
$4.3B
Revenue:
--
EPS (TTM):
-$2.35

Analysts' Opinion

  • Consensus Rating
    Scholar Rock Holding has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $46.38, Scholar Rock Holding has an estimated upside of 1.79% from its current price of $45.56.
  • Price Target Downside
    According to analysts, the lowest downside price target is $33.00 representing 100% downside risk from its current price of $45.56.

Fair Value

  • According to the consensus of 5 analysts, Scholar Rock Holding has 1.79% upside to fair value with a price target of $46.38 per share.

SRRK vs. S&P 500

  • Over the past 5 trading days, Scholar Rock Holding has overperformed the S&P 500 by 1.39% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Scholar Rock Holding does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Scholar Rock Holding has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Scholar Rock Holding reported revenues of --.

Earnings Growth

  • Scholar Rock Holding has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Scholar Rock Holding reported earnings per share of -$0.66.
Enterprise value:
4.2B
EV / Invested capital:
--
Price / LTM sales:
92.18x
EV / EBIT:
--
EV / Revenue:
88.29x
PEG ratio (5yr expected):
-8.96x
EV / Free cash flow:
-22.11x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -$129.3M -$163.7M -$230.7M -$43.7M -$64.8M
EBITDA -$126.3M -$160.8M -$228.5M -$43M -$64.3M
Diluted EPS -$2.79 -$1.95 -$2.35 -$0.53 -$0.66
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $119.4M $258.2M $357.6M $228.5M $152.9M
Total Assets $163.4M $298.4M $390.3M $250.7M $179.1M
Current Liabilities $32.9M $64.6M $33.7M $26.7M $39.4M
Total Liabilities $100.4M $111.1M $97M $83M $99.9M
Total Equity $63M $187.3M $293.3M $167.7M $79.2M
Total Debt -- $24.9M -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$136.2M -$136.8M -$188.8M -$32.3M -$52.5M
Cash From Investing -$142.3M $66.3M $94.2M -$8.5M $35.3M
Cash From Financing $235.5M $5.1M $103.2M $280K $166K
Free Cash Flow -$137.7M -$137M -$188.9M -$32.3M -$52.5M
SRRK
Sector
Market Cap
$4.3B
$46.1M
Price % of 52-Week High
98.65%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
142.99%
-30.52%
Beta (5-Year)
0.578
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $43.27
200-day SMA
Buy
Level $17.16
Bollinger Bands (100)
Buy
Level 9.04 - 35.76
Chaikin Money Flow
Buy
Level 63.1M
20-day SMA
Buy
Level $41.88
Relative Strength Index (RSI14)
Buy
Level 67.29
ADX Line
Buy
Level 24.03
Williams %R
Sell
Level -7.1964
50-day SMA
Buy
Level $34.10
MACD (12, 26)
Buy
Level 3.37
25-day Aroon Oscillator
Buy
Level 48
On Balance Volume
Neutral
Level 166.5M

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 (“TGFβ1”), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Stock Forecast FAQ

In the current month, SRRK has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SRRK average analyst price target in the past 3 months is $46.38.

  • Where Will Scholar Rock Holding Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Scholar Rock Holding share price will rise to $46.38 per share over the next 12 months.

  • What Do Analysts Say About Scholar Rock Holding?

    Analysts are divided on their view about Scholar Rock Holding share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Scholar Rock Holding is a Sell and believe this share price will drop from its current level to $33.00.

  • What Is Scholar Rock Holding's Price Target?

    The price target for Scholar Rock Holding over the next 1-year time period is forecast to be $46.38 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is SRRK A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Scholar Rock Holding is a Buy. 5 of 5 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of SRRK?

    You can purchase shares of Scholar Rock Holding via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Scholar Rock Holding shares.

  • What Is The Scholar Rock Holding Share Price Today?

    Scholar Rock Holding was last trading at $44.94 per share. This represents the most recent stock quote for Scholar Rock Holding. Yesterday, Scholar Rock Holding closed at $45.56 per share.

  • How To Buy Scholar Rock Holding Stock Online?

    In order to purchase Scholar Rock Holding stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 26

Power Solutions International [PSIX] is up 1.01% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 4.86% over the past day.

Buy
75
SMLR alert for Dec 26

Semler Scientific [SMLR] is down 1.56% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock